Aarti Drugs (AARTIDRUGS) Shareholding Pattern

NSE: AARTIDRUGS • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 55.03%
FII Holding 2.15%
DII Holding 10.12%
Public Holding 23.43%
Total Shareholders 148,363
As of Dec 2025
View the latest shareholding pattern of Aarti Drugs (AARTIDRUGS) including promoter, FII, DII, and public holdings. Track AARTIDRUGS ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See Aarti Drugs share price performance)

Aarti Drugs (AARTIDRUGS) Shareholding Summary

  • Promoters have increased holding from 54.72% to 55.03% in Dec 2025
  • FII/FPI have decreased holdings from 2.69% to 2.15% in Dec 2025
  • DIIs have increased holdings from 9.90% to 10.12% in Dec 2025
  • Institutional investors have decreased holdings from 12.59% to 12.27% in Dec 2025
  • Public holding has decreased from 23.58% to 23.43% in Dec 2025
  • Number of shareholders decreased from 152,252 to 148,363 in Dec 2025

AARTIDRUGS Quarterly Ownership Changes

Quarter-over-quarter changes for Aarti Drugs from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
+0.31%
FII Holding Change
Sept 2025 to Dec 2025
-0.54%
DII Holding Change
Sept 2025 to Dec 2025
+0.22%
Public Holding Change
Sept 2025 to Dec 2025
-0.15%

Aarti Drugs (AARTIDRUGS) Quarterly Shareholding Trends

Visual breakdown of AARTIDRUGS ownership distribution over time. Learn more about AARTIDRUGS company valuation.

Promoter
FII
DII
Public
Government

Rising institutional holdings in AARTIDRUGS often correlate with improved fundamentals. Check out Aarti Drugs value estimation.

Aarti Drugs (AARTIDRUGS) Shareholding Data

Download complete AARTIDRUGS ownership data for offline analysis. Discover AARTIDRUGS earnings report.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 55.03% 2.15% 10.12% 0.00% 23.43% 9.27% 100.00% 148,363
Sept 2025 54.72% 2.69% 9.90% 0.00% 23.58% 9.11% 100.00% 152,252
Jun 2025 55.22% 2.26% 9.94% 0.00% 23.69% 8.89% 100.00% 160,260
Mar 2025 55.48% 2.25% 9.70% 0.00% 23.51% 9.06% 100.00% 169,761
Dec 2024 55.38% 2.28% 8.77% 0.00% 24.32% 9.24% 99.99% 176,006
Sept 2024 55.64% 2.50% 7.84% 0.00% 24.80% 9.21% 99.99% 190,281
Jun 2024 55.67% 2.96% 7.35% 0.00% 24.75% 9.27% 100.00% 150,218
Mar 2024 57.13% 2.56% 5.99% 0.00% 25.11% 9.20% 99.99% 157,547
Dec 2023 57.47% 2.10% 5.26% 0.00% 25.84% 9.33% 100.00% 170,414
Sept 2023 58.56% 2.33% 5.32% 0.00% 24.65% 9.14% 100.00% 167,446
Jun 2023 58.70% 0.00% 4.71% 0.00% 25.34% 11.25% 100.00% 162,409
Mar 2023 59.58% 0.00% 4.09% 0.00% 25.72% 10.61% 100.00% 169,090
Dec 2022 59.66% 0.00% 3.90% 0.00% 25.98% 10.46% 100.00% 173,283
Sept 2022 59.77% 0.00% 3.16% 0.00% 26.66% 10.41% 100.00% 180,303
Jun 2022 59.98% 0.00% 2.76% 0.00% 32.16% 5.10% 100.00% 186,674
Mar 2022 59.83% 0.00% 2.69% 0.00% 32.02% 5.46% 100.00% 189,607
Dec 2021 59.99% 0.00% 2.28% 0.00% 32.85% 4.89% 100.01% 195,469
Sept 2021 60.12% 0.00% 2.09% 0.00% 32.68% 5.11% 100.00% 183,344
Jun 2021 60.14% 0.00% 1.97% 0.00% 32.32% 5.57% 100.00% 177,992
Mar 2021 60.20% 0.00% 1.59% 0.00% 31.86% 6.36% 100.01% 173,704

AARTIDRUGS promoter holding above 50% indicates strong insider confidence. Explore the AARTIDRUGS P/E ratio for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 55.03% 2.15% 10.12% 0.00% 23.43% 9.27% 100.00% 148,363
Sept 2025 54.72% 2.69% 9.90% 0.00% 23.58% 9.11% 100.00% 152,252
Jun 2025 55.22% 2.26% 9.94% 0.00% 23.69% 8.89% 100.00% 160,260
Mar 2025 55.48% 2.25% 9.70% 0.00% 23.51% 9.06% 100.00% 169,761
Dec 2024 55.38% 2.28% 8.77% 0.00% 24.32% 9.24% 99.99% 176,006
Sept 2024 55.64% 2.50% 7.84% 0.00% 24.80% 9.21% 99.99% 190,281
Jun 2024 55.67% 2.96% 7.35% 0.00% 24.75% 9.27% 100.00% 150,218
Mar 2024 57.13% 2.56% 5.99% 0.00% 25.11% 9.20% 99.99% 157,547
Dec 2023 57.47% 2.10% 5.26% 0.00% 25.84% 9.33% 100.00% 170,414
Sept 2023 58.56% 2.33% 5.32% 0.00% 24.65% 9.14% 100.00% 167,446
Jun 2023 58.70% 0.00% 4.71% 0.00% 25.34% 11.25% 100.00% 162,409
Mar 2023 59.58% 0.00% 4.09% 0.00% 25.72% 10.61% 100.00% 169,090

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 55.03% 2.15% 10.12% 0.00% 23.43% 9.27% 100.00% 148,363
Dec 2024 55.38% 2.28% 8.77% 0.00% 24.32% 9.24% 99.99% 176,006
Dec 2023 57.47% 2.10% 5.26% 0.00% 25.84% 9.33% 100.00% 170,414
Dec 2022 59.66% 0.00% 3.90% 0.00% 25.98% 10.46% 100.00% 173,283
Dec 2021 59.99% 0.00% 2.28% 0.00% 32.85% 4.89% 100.01% 195,469

Year-over-year trends reveal long-term ownership shifts.

Understanding Aarti Drugs (AARTIDRUGS) Shareholding Pattern

Aarti Drugs shareholding pattern reveals who owns AARTIDRUGS stock and how ownership changes over time. High promoter stakes in AARTIDRUGS often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your AARTIDRUGS trades. AARTIDRUGS true value

Combine AARTIDRUGS ownership analysis with price movements and financial performance for a complete investment picture. (See Aarti Drugs yearly highs lows)